Search
Search
Multiplexing is a technique that allows for the simultaneous detection and differentiation of multiple target sequences in a single reaction using real-time PCR (qPCR). Multiplexing involves designing specific primers and probes for each target of interest and optimizing reaction conditions to enable accurate and reliable results. By eliminating the need for individual reactions for each target organism, multiplexing can help provide the advantages of saving time, resources, and costs. With a single reaction, multiple pathogens or genetic markers can be detected, enabling faster turnaround times and helping to streamline and optimize the productivity of your testing process.
qPCR multiplexing, while advantageous, does come with its challenges. One of the main difficulties is the optimization of primer and probe combinations to enable the specific and efficient amplification of each target in the multiplex reaction. Another challenge lies in managing potential cross-reactivity or interference between different targets, which may require additional optimization steps to minimize false positives or inaccurate quantification. Careful experimental design and thorough validation are crucial to overcoming these challenges, helping to support the reliability and accuracy of multiplex qPCR results.
We offer pre-designed and qualified multiplex panels for detecting a broad range of infectious pathogens and resistance genes in research applications for vaginal / women’s health, respiratory infections, sexually transmitted infections, gastrointestinal infections, nail fungal infections, antimicrobial / drug resistance and more.
These panels are made to order and customizable to be reconfigured with your specified targets of interest:
|
|
Pre-designed panels |
Qualified panels |
In-silico analysis |
No high-risk oligo interactions identified |
|
|
Inclusivity (maximized strain coverage) |
|
|
|
Additional functional testing |
Analytical sensitivity |
|
|
| Linear dynamic range |
|
|
|
| Competitive interference (if applicable) |
|
|
| Panel name | Beta-lactamase and Quinolone Resistance | Carbapenemase and Beta-Lactamase Resistance | Extended-Spectrum Beta-Lactamase and Quinolone Resistance | |
|---|---|---|---|---|
| Multiplex ID | Ba00000009_gmplx | Ba00000011_gmplx | Ba00000010_gmplx | |
| Testing level | Pre-designed | Pre-designed | Pre-designed | |
| Targets | Beta-lactamase ampC1 | |||
| Carbapenem-hydrolyzing class A beta-lactamase KPC (blaKPC) | ||||
| Cephalosporin-hydrolyzing class C beta-lactamase blaFOX | blaACC | ||||
| Class A beta-lactamase SHV (blaSHV) | ||||
| Class A extended-spectrum beta-lactamase CTX-M (blaCTX-M) | ||||
| Class A extended-spectrum beta-lactamase PER | ||||
| OXA-48 family class D beta-lactamase OXA (blaOXA) | ||||
| Quinolone resistance pentapeptide repeat protein (QnrB) | ||||
| Quinolone resistance pentapeptide repeat protein QnrA | QnrS | ||||
| Subclass B1 metallo-beta-lactamase VIM|NDM|IMP | ||||
| Control | Bacillus atrophaeus | |||
| Panel name | Cephalosporin resistance: ESBLs | Carbapenem resistance | Carbapenem resistance: OXA-type | Quinolone resistance |
|---|---|---|---|---|
| Multiplex ID | Ba00000373_gmplx | Ba00000374_gmplx | Ba00000375_gmplx | Ba00000389_gmplx |
| Testing level | Qualified | Qualified | Qualified | Qualified |
| Targets |
|
|
|
|
| Controls | Bacillus atrophaeus | |||
| Panel name | Macolide and tetracycline resistance | Plasmid-mediated beta-lactamase resistance: AmpC and OXA-type | Sulfonamides & trimethoprim resistance | Vancomycin and beta-lactam resistance |
|---|---|---|---|---|
| Multiplex ID | Ba00000402_gmplx | Ba00000399_gmplx | Ba00000400_gmplx | Ba00000401_gmplx |
| Testing level | Qualified | Qualified | Qualified | Qualified |
| Targets |
|
|
|
|
| Controls | Bacillus atrophaeus | |||
| Panel name | Astrovirus, Adenovirus, ETEC (Enteric) | Bacteroides, Enterovirus, Vibrio (Enteric and Environment) | Sapovirus (Gastroenteritis) | Yersinia, Clostridium difficile (Enteric) | |
|---|---|---|---|---|---|
| Multiplex ID | Pa00000012_gmplx | Ba00000014_gmplx | Vi00000018_gmplx | Pa00000013_gmplx | |
| Testing level | Pre-designed | Pre-designed | Pre-designed | Pre-designed | |
| Targets | Adenovirus F40/41 | ||||
| Astrovirus | |||||
| Bacteroides fragilis | |||||
| Clostridium difficile toxin A/B | |||||
| Enterotoxigenic E. coli (ETEC) | |||||
| Enterovirus | |||||
| Sapovirus GII.5 / GII.8 / GIV.1 / GV | |||||
| Sapovirus I / GII / IV | |||||
| Vibrio cholerae / Vibrio parahaemolyticus / Vibrio vulnificus | |||||
| Yersinia enterolitica | |||||
| Control | Bacillus atrophaeus | ||||
| Panel name | Candida Differentiation | Dermatophyte 1 | Fusarium, Trichophyton, Aspergillus, Candida |
Non- Dermatophyte 1 |
|---|---|---|---|---|
| Multiplex ID | Fn00000034_gmplx | Fn00000030_gmplx | Fn00000020_gmplx | Fn00000033_gmplx |
| Testing level | Pre-designed | Pre-designed | Pre-designed | Pre-designed |
| Targets |
|
|
|
|
| Panel name | Candida Differentiation | Dermatophyte 1 |
Fusarium, Trichophyton, Aspergillus, Candida | Non-Dermatophyte 1 |
|---|---|---|---|---|
| Multiplex ID | Fn00000032_gmplx | Fn00000029_gmplx | Fn00000019_gmplx | Fn00000031_gmplx |
| Testing level | Qualified | Qualified | Qualified | Qualified |
| Targets |
|
|
|
|
| Panel name | Fusarium, Scopulariopsis, Candida - R | Trichophyton, Candida, Aspergillus - R | Trichophyton, Candida, Fusarium - R |
Trichophyton, Candida, Scopulariopsis - R |
|---|---|---|---|---|
| Multiplex ID | Fn00000269_gmplx | Fn00000266_gmplx | Fn00000267_gmplx | Fn00000268_gmplx |
| Testing level | Pre-designed | Pre-designed | Pre-designed | Pre-designed |
| Targets |
|
|
|
|
| Panel name | Bordetella differentiation (Whooping cough) | Coronavirus differentiation | FluA, FluB, FluA H5N1, SARS‑CoV‑2 | Flu A, Flu B, RSV | Parainfluenza differentiation | |
|---|---|---|---|---|---|---|
| Multiplex ID | Ba00000054_gmplx | Vi00000053_gmplx | Vi00000181_gmplx | Vi00000052_gmplx | Vi00000045_gmplx | |
| Testing level | Qualified | Qualified | Qualified | Qualified | Qualified | |
| Targets | Bordetella holmesii | |||||
| Bordetella parapertussis | ||||||
| Bordetella pertussis | ||||||
| Coronavirus OC43 | ||||||
| Coronavirus HKU1 | ||||||
| Coronavirus 229E | ||||||
| Coronavirus NL63 | ||||||
| Influenza A | ||||||
| Influenza A H5N1 | ||||||
| Influenza B | ||||||
| Parainfluenza 1 | ||||||
| Parainfluenza 2 | ||||||
| Parainfluenza 3 | ||||||
| Parainfluenza 4 | ||||||
| RSV | ||||||
| SARS-CoV-2 | ||||||
| Control | RNase P | |||||
| Panel name | Legionella, C. burnetii, Group A Strep, P. jirovecii | S. pneumoniae, H. influenzae, M. pneumoniae, Group B Strep | S. aureus, M. catarrhalis, K. pneumoniae, C. pneumoniae |
|---|---|---|---|
| Multiplex ID | Ba00000405_gmplx | Ba00000403_gmplx | Ba00000404_gmplx |
| Testing level | Qualified | Qualified | Qualified |
| Targets |
|
|
|
| Control |
RNase P | ||
| Panel name | Bocavirus, Paraechovirus, Flu C | Metapneumovirus, Adenovirus | Rhinovirus / Enterovirus |
|---|---|---|---|
| Multiplex ID | Vi00000408_gmplx | Vi00000406_gmplx | Vi00000407_gmplx |
| Testing level | Qualified | Qualified | Qualified |
| Targets |
|
|
|
| Control | RNase P | ||
| Panel name | Herpes Simplex |
|---|---|
| Multiplex ID | Vi00000004_gmplx |
| Testing level | Qualified |
| Targets |
|
| Control | RNase P |
| Panel name | Vaginal pathogen | Vaginal profile | Vaginal candida | |
| Multiplex ID | Pa00000001_gmplx | Ba00000002_gmplx | Fn00000041_gmplx | |
| Testing level | Qualified | Qualified | Qualified | |
| Targets | Atopobium vaginae | |||
| Candida dubliniensis / Candida albicans / Candida parapsilosis / Candida tropicalis | ||||
| Candida glabrata | ||||
| Candida glabrata / Candida krusei | ||||
| Candida krusei | ||||
| Gardnerella vaginalis | ||||
| Lactobacillus jensenii / Lactobacillus crispatus / Lactobacillus gasseri | ||||
| Megasphaera 1 | ||||
| Trichomonas vaginalis | ||||
| Control | RNase P | |||
| Panel name | Human Papillomavirus Low Risk 1 | Human Papillomavirus Low Risk 2 | Human Papillomavirus High Risk |
|---|---|---|---|
| Multiplex ID | Vi00000395_gmplx | Vi00000397_gmplx | Vi00000396_gmplx |
| Testing level | Qualified | Qualified | Qualified |
| Targets |
|
|
|
| Control | RNase P | ||
| Panel name | Urinary Tract Microbiota 1 | Urinary Tract Microbiota 2 | Urinary Tract Microbiota 3 | Urinary Tract Microbiota 4 |
| Multiplex ID | Pa00000338_gmplx | Pa00000339_gmplx | Ba00000340_gmplx | Ba00000273_gmplx |
| Testing level | Qualified |
|||
| Targets |
Aerococcus urinae | Candida auris | Actinobaculum schaalii | Acinetobacter baumannii |
| Candida albicans | Candida parapsilosis | Coagulase-negative staphylococci | Klebsiella pneumoniae | |
| Citrobacter freundii | Escherichia coli | Mycoplasma hominis | Morganella morganii | |
| Candida glabrata | Proteus mirabilis | Providencia stuartii | ||
| Control | Bacillus atrophaeus | |||
| Panel name | Urinary Tract Microbiota 5 | Urinary Tract Microbiota 6 | Urinary Tract Microbiota 7 | Urinary Tract Microbiota 8 |
| Multiplex ID | Ba00000342_gmplx | Ba00000275_gmplx | Ba00000343_gmplx | Ba00000344_gmplx |
| Testing level | Qualified |
|||
| Targets |
Alloscardovia omnicolens | Corynebacterium riegelii | Enterobacter aerogenes | Pseudomonas aeruginosa |
| Citrobacter koseri | Enterococcus faecalis | Enterobacter cloacae | Pantoea agglomerans | |
| Enterococcus faecium | Serratia marcescens | Klebsiella oxytoca | Proteus vulgaris | |
| Ureaplasma urealyticum | Viridans group streptococci | Staphylococcus aureus | Streptococcus agalactiae | |
| Control | Bacillus atrophaeus | |||
| Panel name | Anaplasmosis and Ehrlichiosis | Lyme Disease, Hard Tick Relapsing Fever | Rickettsia, F. tularensis, C. burnetii | Soft Tick Relapsing Fever |
|---|---|---|---|---|
| Multiplex ID | Ba00000387_gmplx | Ba00000385_gmplx | Ba00000388_gmplx | Ba00000386_gmplx |
| Testing level | Qualified | Qualified | Qualified | Qualified |
| Targets |
|
|
|
|
| Panel name | Babesiosis | Tick-Borne RNA Virus 1 | Tick-Borne RNA Virus 2 |
|---|---|---|---|
| Multiplex ID | Pr00000390_gmplx | Vi00000391_gmplx | Vi00000392_gmplx |
| Testing level | Qualified | Qualified | Qualified |
| Targets |
|
|
|
For Research Use Only. Not for use in diagnostic procedures.